Blue Earth Diagnostics Highlights Presentations on POSLUMA (Flotufolastat F 18) in Prostate Cancer at Upcoming ASTRO Annual Meeting
Imaging Technology
SEPTEMBER 27, 2023
“PET imaging with POSLUMA reveals clinical information crucial to decision-making for men with prostate cancer, and we are excited to share further information with the radiation oncology community at ASTRO 2023,” said David E. POSLUMA use contributes to a patient’s overall long-term cumulative radiation exposure.
Let's personalize your content